The current stock price of MYL is 15.855 null. In the past month the price increased by 2.82%. In the past year, price decreased by -8.56%.
ChartMill assigns a technical rating of 4 / 10 to MYL. When comparing the yearly performance of all stocks, MYL is a bad performer in the overall market: 78.99% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to MYL. There are concerns on the financial health of MYL while its profitability can be described as average.
Over the last trailing twelve months MYL reported a non-GAAP Earnings per Share(EPS) of 4.73. The EPS increased by 9.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.31% | ||
| ROA | 0.85% | ||
| ROE | 2.12% | ||
| Debt/Equity | 0.8 |
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Mylan NV Ord Shs
1000 MYLAN BOULEVARD
CANONSBURG PA 15317
CEO: Heather Bresch
Phone: 724-514-1800
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
The current stock price of MYL is 15.855 null. The price increased by 1.96% in the last trading session.
MYL does not pay a dividend.
MYL has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MYL.
You can find the ownership structure of Mylan NV Ord Shs (MYL) on the Ownership tab.